However, CA125 is not a specific biomarker for ovarian cancer detection, as its levels may increase in healthy individuals depending on the phase of the menstrual cycle or pregnancy and several pathological conditions, i.e., ovarian cysts, endometriosis, and hepatitis [26]. The gene discussed is MUC16; the disease is ovarian carcinoma.